Atlas Trials

A Study to Assess Safety and Pharmacokinetics of Telaprevir in Patients With Hepatic Impairment

Clinical trial NCT01600976 · COMPLETED

Trial details

NCT number
NCT01600976
Sponsor
Janssen Infectious Diseases BVBA
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatic Impairment
Start date
2012-06-01
Primary completion
2012-10-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.